Skip to search formSkip to main content

Actinium Ac 225 Lintuzumab

Known as: 225Ac-HuM195, Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195 
A radioimmunoconjugate consisting of the humanized monoclonal antibody lintuzumab conjugated to the alpha-emitting radioisotope actinium Ac 225 with… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Targeted α therapy holds tremendous potential as a cancer treatment: it offers the possibility of delivering a highly cytotoxic… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2015
Review
2015
Acute myeloid leukemia (AML) is the second most common form of leukemia and the most frequent cause of leukemia-related deaths in… Expand
  • figure 1
  • table 1
Is this relevant?
2008
2008
HuM195, a humanized anti-CD33 monoclonal antibody, targets myeloid leukemia cells and has single-agent activity against acute… Expand
Is this relevant?
2004
2004
UNLABELLED Short-lived alpha-emitting isotopes individually conjugated to monoclonal antibodies have now reached human use, but… Expand
Is this relevant?
1995
1995
Humanized M195 (HuM195) is a genetically engineered, human IgG1 version of the parent M195, a mouse immunoglobulin G2a, anti-CD33… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?